Previously, the increased P4HA1 expression correlates with poor prognosis has been demonstrated in several cancers, including breast cancer, oral squamous cell carcinoma, melanoma, and prostate cancer [63,64,65,66]. Here, P4HA1 is linked to prostate cancer.